Calidi Biotherapeutics (CLDI) Shares Outstanding (Diluted Average) (2021 - 2025)
Calidi Biotherapeutics' quarterly Shares Outstanding (Diluted Average) came in at $4302.0 in Q4 2025, up 544.98% year-on-year from $667.0 in Q4 2024, and up 27.96% quarter-over-quarter from $3362.0 in Q3 2025.
Calidi Biotherapeutics has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $4302.0 in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 544.98% year-over-year to $4302.0; the trailing twelve-month figure through Dec 2025 stood at $4302.0 (up 544.98% YoY), and the FY2025 full-year result was $4302.0, up 544.98% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $4302.0, up from $3362.0 in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $8.9 million in Q4 2021, with the low at $444.0 in Q2 2024.
- Average Shares Outstanding (Diluted Average) over 5 years is $2.9 million, with a median of $878000.0 recorded in 2023.
- Year-over-year, Shares Outstanding (Diluted Average) plunged 99.96% in 2024 and soared 661.91% in 2025.
- Tracing CLDI's Shares Outstanding (Diluted Average) over 5 years: stood at $8.9 million in 2021, then retreated by 4.33% to $8.5 million in 2022, then slumped by 80.18% to $1.7 million in 2023, then sank by 99.96% to $667.0 in 2024, then surged by 544.98% to $4302.0 in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $4302.0 (Q4 2025), $3362.0 (Q3 2025), and $2877.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | 4,302.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,302.00 |
| Sep 30, 2025 | 3,362.00 |
| Jun 30, 2025 | 2,877.00 |
| Mar 31, 2025 | 27,086.00 |
| Dec 31, 2024 | 667.00 |
| Sep 30, 2024 | 652.00 |
| Jun 30, 2024 | 444.00 |
| Mar 31, 2024 | 3,555.00 |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 878,000.00 |
| Mar 31, 2023 | 8.66 Mn |
| Dec 31, 2022 | 8.51 Mn |
| Sep 30, 2022 | 8.48 Mn |
| Jun 30, 2022 | 5.75 Mn |
| Mar 31, 2022 | 5.75 Mn |
| Dec 31, 2021 | 8.89 Mn |